Nice Insight has compiled primary and secondary data to assess market trends, practices, and pricing for oral solid dose (OSD) drugs, including their formulation, development, and manufacturing. This report provides insights into each OSD segment, ongoing innovations, current processes, therapies in the pipeline, and regional activity.
A proprietary pricing study provides data for both buyers and sellers of services, with prevailing practices in the bundling of integrated formulation, development, and manufacturing of finished drug products in a range of solid dose forms. A directory of the leading players in major regions with a full listing of services offers readers insight into the global competitive landscape.
If you are a CDMO serving the OSD outsourcing market — or a PE company or investor looking to refine your investing strategy with a comprehensive landscape of the market — you need our Oral Solid Dose Market Growth and Contract Manufacturing Report with Pricing Study to explore the competitive environment, examine how your pricing compares with your peers, and position your company more effectively to attract business. Access pricing data across a range of criteria and parameters spanning the full range of OSD products and processes.
If you are a innovator looking to outsource your OSD development and manufacturing or seeking cost-efficient services for generics manufacturing, our Oral Solid Dose Market Growth and Contract Manufacturing Report with Pricing Study is an invaluable resource to find the ideal OSD CDMO with all of the services to fit your needs. Understand what you should pay by product type, process, and volume with competitive pricing comparisons.
Core Deliverables of This Market Report
Gain More Understanding Of:
Gwenael Servant, Ph.D.
Managing Director, Europe
Business Director, Partner
Account & Sales Executive